Background: Lifestyle interventions reduce cardiovascular risk and risk of diabetes mellitus, but reports on long-term effects on quality of life (QOL) and health care utilization are rare. We investigated the impact of a primary health care-based lifestyle intervention program on QOL and cost-effectiveness over 3 years.
P
EOPLE WHO ARE SEDENTARY have a higher relative risk of mortality than the physically active, and unfit people have a higher risk than fit people. [1] [2] [3] Most people in developed countries do not reach the recommended level of physical activity (PA), 4 thereby contributing to public health problems. 5 Extensive and intensive lifestyle intervention programs delay the onset of diabetes mellitus (DM) and reduce cardiovascular risk by increasing PA, reducing overweight, and making changes in dietary habits. 6 Health-related quality of life (QOL) is a patient-centered outcome and incorporates the patient's perspective of physical, mental, and social well-being. Individuals with obesity, DM, and other cardiovascular risk factors, such as hypertension and hyperlipidemia, report diminished wellbeing and QOL, 7, 8 whereas being active is associated with a higher QOL. 9, 10 For a comprehensive assessment of an intervention program it is essential to incorporate the individual's broader perspective of well-being, not only the conventional medical outcomes. 11 One recent randomized controlled trial (RCT) 12 showed a dose-response effect of PA on both physical and mental aspects of QOL. Otherwise, reports on the long-term effect of programs for increased PA on QOL are rare, inconsistent, and very seldom performed in primary health care. [13] [14] [15] [16] [17] [18] Despite the evidence that health care can promote PA and that it is an effective treatment method, its promotion is rarely used as standard care.
An important factor in the selection of interventions in health care should be the costeffectiveness compared with competing methods. A systematic review 19 found no report concerning cost-effectiveness of PA promotion in primary health care used as a treatment method alongside standard care.
We recently reported a 3-year follow-up on an RCT with lifestyle intervention performed in a primary health care setting. 20 It involved a population at moderate-to-high risk for cardiovascular disease and favorably reduced several risk factors. Our hypothesis was that the program improved QOL and was cost-effective.
PARTICIPANTS, RANDOMIZATION, AND BLINDING
The study population was recruited from a primary care center in northern Sweden. Individuals 18 to 65 years old with hypertension, dyslipidemia, type 2 DM, obesity, or any combination thereof, were identified. Individuals with a diagnosis of coronary heart disease, stroke, severe hypertension, and severe psychiatric morbidity were excluded. The 340 eligible individuals at University Library of Southern Denmark, on February 3, 2012 www.archinternmed.com Downloaded from were invited by letter, and 177 (52%) agreed to participate. Of those, 18 withdrew before randomization, and an additional 8 met the study's exclusion criteria. A total of 151 enrolled participants were randomly allocated to the intervention group (n=75) or the control group (n=76), using a computer-generated random numbers sequence. The allocation was concealed until after the baseline examinations were completed. There was no blinding.
INTERVENTION
The intervention consisted of supervised progressive exercise training 3 times a week and diet counseling on 5 occasions during the first 3 months, followed by regular group meetings. All activities were performed in small groups (n=10-13). The exercise sessions were led by physiotherapists and consisted of Nordic walking, aqua-aerobics, and interval training on a bicycle ergometer combined with circuit-type resistance training. Each training group was offered 1 session of each activity every week. The diet counseling was in accordance with the Nordic nutrition recommendations and was given both verbal and written by a trained dietician.
After the 3-month active intervention period, participants were invited to attend group meetings on 6 occasions during the first year, on 4 occasions during the second year, and on 2 occasions during the third year. Participants were encouraged to maintain at least 30 minutes/d of PA. The focus was on selfregulatory strategies, such as goal-setting, action planning, and relapse avoidance. Participants were asked to reflect on benefits, barriers, and costs of adherence to a healthier lifestyle.
The control group was given both verbal and written information about exercise and diet at 1 group meeting. Both groups were requested to complete activity logs and continued with their routine care.
OUTCOMES
Primary outcomes were change in QOL measured as the 5-dimensional EuroQol 5D (EQ-5D), the EuroQol visual analog scale (EQ-VAS), and the 6-dimensional Short-Form 6D (SF-6D) based on the self-administrated generic questionnaires EuroQol (EQ) and the 36-Item Short-Form-Health Survey (SF-36); gained QALYs; and change in resource use.
The EQ includes the EQ-5D self-classifier, 21 a descriptive system that measures 5 dimensions of health status: mobility, self-care, usual activities, pain/discomfort, and anxiety/ depression. We computed a single score based on the value tariff from a British population. 22 The EQ-VAS records the respondent's perception of overall health status on a 20-cm line graduated from 0 (indicating worst imaginable health) to 100 (indicating best imaginable health). We transformed the EQ-VAS to a 0 to 1 scale by dividing the actual score by 100.
The SF-36 consists of 36 items grouped into 8 domains: physical functioning, limitations in physical role functioning, bodily pain, general health, vitality, social functioning, limitations in emotional role functioning, and mental health. 23 Each domain is scored from 0 (worst imaginable health) to 100 (best imaginable health) obtained from the patient's raw scales. Changes greater than 3 to 5 scale points may be clinically relevant. 24 The SF-36 physical component summary score and mental component summary score were calculated using the Swedish manual. 23 The SF-6D is a utility score derived from responses to 11 questions in the SF-36 questionnaire and consists of 6 dimensions of health. 25, 26 
HEALTH ECONOMIC ANALYSIS METHOD
The analysis in this study was a cost-utility analysis with a societal perspective. Cost-effectiveness ratios were based on gained QALYs and net costs for the intervention group compared with the control group. In the analysis, costs for stakeholder of intervention, patients' costs, treatment effect, and savings in health care use were considered, but not the cost for the participants' exercise time or changes in production.
Health care utilization data were extracted from electronic patient records from all health care centers and hospitals in the county, and were followed from 6 months before the start of the intervention to 3 years after the intervention was started.
Measurements made at baseline and at the follow-ups that were used in the calculation are given in Table 1 . All costs were transformed from Swedish currency to US dollars using the exchange rate of 1 US dollar=7.5 Swedish krona. Costs were recalculated to the price level of 2009 using the Swedish consumer price index. Research costs and costs relating to the development of the method were not included. All changes in effect and costs were discounted 3% per year.
The uncertainty from the underlying trial was handled with the net monetary benefit (NMB) method, 29 which is based on replacing health effects (QALYs) with the amount of money decision makers are willing to pay for a gained qualityadjusted life-year (QALY). When both effects and resource use SF-6D in combination with preference scores from a British population 25, 26 Savings Health care costs Health care records regarding the last 6 mo of health care use before baseline and the 3-y use after start of the intervention. Number of visits to family physicians and nurses in primary health care and number of visits and admissions in hospital care were counted. Standard production prices negotiated for trade of health care between county councils were used
Abbreviations: EQ-5D, 5-dimensional EuroQol-5D; EQ-VAS, EuroQol visual analog scale; PA, physical activity; QOL, quality of life; SF-6D, 6-dimensional Short-Form 6D.
are expressed in monetary units, it is possible to calculate a 95% confidence interval for cost-effectiveness and the probability that an intervention is cost-effective in relation to a competing intervention.
A gained QALY is calculated from the difference in QOL between the intervention and control groups at the follow-up times. Differences were assumed to develop linearly between follow-up times. For instance, if QOL had increased 0.04 more at 3 months and 0.08 more at 1 year in the intervention group than in the control group, the mean change during the first 3 months would be 0.02 [(0.00ϩ0.04)/2] and for the following 9 months it would be 0.06 [(0.04 ϩ0.08)/2]. Gained QALY for this year would be 0.05
A scatterplot of 5000 bootstrapped incremental cost-effectiveness ratios was created by repeatedly drawing a random sample with replacement using parameters estimated from the RCT. Individual values were used for savings in health care costs and gained QALY, and mean values were used for costs in intervention and control groups. This produced estimates of the probability that the intervention was cost-effective using several thresholds of willingness to pay for a QALY. Results are presented in a cost-effectiveness acceptability curve. 30 Furthermore, mean NMB and 95% confidence intervals of NMB were estimated for these different threshold values.
STATISTICAL ANALYSES
Differences between groups in changes in outcome variables over 3 years were analyzed on an intention-to-treat (ITT) basis. If data were missing, the last observation was carried forward. The general linear model with repeated measures of variance was used to investigate mean changes in QOL over time and overall main effects, testing also for the effects of time and the interaction between group and time. For exploratory reasons, all outcomes were also analyzed per-protocol using only available data and were also adjusted for age and sex. These results did not differ substantially from the unadjusted ITT analysis, which therefore is presented. We used t tests, with Bonferroni correction when needed, for comparison at singular time points.
We calculated a statistical index of responsiveness, effect size, as standardized response mean according to Cohen. 31 A change in effect size of 0.2 to 0.5 should be regarded as "small," greater than 0.5 to 0.8 as "moderate," and greater than 0.8 as "large."
RESULTS
A total of 151 individuals were randomized, with the greatest attrition occurring during the first year. The number lost to follow-up did not differ substantially between the groups: 17 in the intervention group and 14 in the control group. Six individuals were excluded: 4 did not start the intervention, and 2 from the control group had incomplete baseline data ( Figure 1) . Finally, 71 intervention and 74 control participants were included, and the 3-year follow-up was completed by 120 participants (83%).
OUTCOMES AND ESTIMATIONS
The mean age of the study population was 54.4 years, and 57% were female ( Table 2) . Overweight or obesity was present in 86.8%, and most had 1 or more additional risk factors. An inactive lifestyle was common; 54.5% were sedentary or minimally active, and 84.2% reported no exercise or less than 30 minutes of exercise per day. Smoking, DM, and treatment with lipidlowering drugs were more common in the intervention group, while hypertensive medication was less common. The intervention groups tended to be less physi- Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); EQ-5D, 5-dimensional EuroQol-5D; EQ-VAS, EuroQol visual analog scale; SF-6D, 6-dimensional Short-Form 6D; SF-36, 36-Item Short-Form Health Survey.
a Age, SF-36, and EuroQol data are given as mean (SD); other variables are given as number (percentage).
cally active and reported lower mean scores in all QOL questions at baseline.
The EQ-5D score and the mental dimensions of the SF-36 were similar to those in the general Swedish population, 23, 32 whereas the scores for the EQ-VAS and the physical dimensions of the SF-36 were lower (Figure 2) . Problems in the pain/discomfort dimension were more common and problems in the anxiety/depression dimension were less common than in the general population of Stockholm 32 ( Figure 2C ).
QUALITY OF LIFE
The EQ-5D scores did not change significantly during the 3-year period (see Table 3 for P values). However, the EQ-VAS scores differed significantly between the groups over the 3-year period (P=.002), with greater improvement in the intervention group. The improvement in the SF-6D mean score was higher in the intervention group than in the control group (P = .01). Mean changes in scores and summaries in the SF-36 dimensions are shown in Table 3 . Over 3 years an improved physical functioning (P=.02) and less bodily pain (P=.01) were found in the intervention group. The physical component summary improved to a higher degree in the intervention group (P=.04) but not the mental component summary or its subscales.
There were no significant main time effects or interaction effects between time and group for most QOL variables. But in the SF-36 bodily pain dimension, groups were changing in different directions over time, increasing in the intervention group and decreasing in the control group (Table 3 ). In addition, vitality and social functioning scores showed a significant interaction over time: the intervention group improving and the control group decreasing slightly. The main time effect was significant only for social functioning (P=.005). Calculations of the effect size at the 3-year follow-up showed moderate effects on the EQ-VAS, SF-6D, bodily pain, and physical component summary, and small-to-moderate effects on physical functioning (Table 3) .
COSTS
Costs were $337 higher for the intervention group than for the control group: $197 of those costs were financed by health care, and the remaining $140 were costs imposed on the participants owing to increased PA Abbreviations: CI, confidence interval; EQ-5D, 5-dimensional EuroQol-5D; EQ-VAS, EuroQol visual analog scale; SF-6D, 6-dimensional Short-Form 6D; SF-36, 36-Item Short-Form Health Survey.
a Data are given as estimated marginal means (95% CI) derived from a general linear model with repeated measures. P values for group differences at each time point were assessed by independent sample t test using Bonferroni correction when significant effect between time and group interaction effect. Effect size according to Cohen's criteria 31 : trivial, less than 0.20; small, 0.2 to 0.5; moderate, 0.5 to 0.8; large, more than 0.8. (Table 4) . Costs for medical testing, such as serum lipids, glucose, and hemoglobin A 1c levels, were $185 per patient and year for both intervention and control groups. (Costs are given in US dollars except where indicated.)
GAINED QALY
Gained QALY per participant in the intervention group compared with the control group during the 3 years was 0.08 (P=.24) using the EQ-5D, 0.20 (P Ͻ .01) using the EQ-VAS, and 0.07 (P = .03) using the SF-6D (discounted 3% per year).
SAVINGS
The mean number of visits to the family physician in the intervention group decreased by 0.28 per half-year compared with baseline, and increased by 0.10 in the control group (P=.04). For other health care use there were no notable changes between the groups. Savings in family physician visits was $493 for the 3-year period, and savings for all health care use was $384 (P=.44) ( Table 4) .
COST-EFFECTIVENESS
There were net savings of $47 per participant in the intervention group compared with the control group. Gross costs per gained QALY were $1668 to $4813 using the 3 different QOL scales ( Table 5) . Using $50 000 as the threshold of willingness to pay for a QALY, the probability of cost-effectiveness is 0.985 using the SF-6D, 0.886 using the EQ-5D, and 0.999 using the EQ-VAS (Figure 3) .
COMMENT
To our knowledge, the Björknäs study demonstrates for the first time that a lifestyle intervention over 3 years, targeted to a population at moderate-to-high risk for CVD, performed in "real life" primary health care, improves QOL and is highly cost-effective. The intervention used the core features of the American Diabetes Prevention Program 13 and the Finnish Diabetes Prevention Study 33 but was delivered at a conventional primary care setting in a Prices for health care are negotiated and represent production costs. For hospital visits, costs for visits to the internal medicine clinic were used. Ninety-five percent confidence intervals are presented within brackets. All costs and savings are in US dollars and were discounted 3% per year. northern Sweden, without additional resources. These results should be viewed in the context of the previously reported favorable impact on PA, fitness, waist circumference, waist-to-hip ratio, blood pressure, and smoking cessation over the 3-year period. 20 We have not been able to find any previous reports on the effect on QOL or cost-effectiveness of group-based lifestyle interventions in primary health care, focusing on PA with a follow-up over many years.
PA AND QOL
People with obesity and other cardiovascular risk factors have lower QOL, 7, 8 and obese patients have more problems regarding mobility and pain 7 in concordance with our comparison with the Swedish population. Women with higher levels of exercise report higher QOL. 34 The causality between higher level of PA and improved QOL was recently confirmed in an RCT with sedentary postmenopausal women, which demonstrated a strong and graded effect of 3 different doses of supervised exercise on QOL over a 6-month period. 12 Even a small increase in exercise was associated with improvements in some SF-36 dimensions. The magnitude of improvements in QOL was similar to the results in our study, with better physical and mental health after the initial supervised exercise period. We noted that the mental improvement waned over a longer period, in accordance with other lifestyle interventions. 17, 18 The effects of PA on QOL in clinical trials are inconsistent, the methods to promote it differ, [13] [14] [15] [16] some studies include only women 12 or have short follow-up. "Physical activity on prescription" involves a health professional's written advice to a patient to be more physically active. Some RCTs in primary care, using PA on prescription but not supervised exercise sessions, report no effect on QOL or fitness at a 6-month follow-up, 14 or some improvements in QOL after 2 years. 16 The ProActive study 15 targeted a sedentary population at risk of DM and investigated the effects of a theorybased behavioral intervention. The program taught behavior change and was delivered regularly for 1 year by health professionals by telephone or in participants' homes. The intervention was not more effective than written advice to promote PA or improve fitness but improved some SF-36 scales.
PA AND COST-EFFECTIVENESS
Costs per gained QALY were low ($1668-$4813). When savings in health care were also considered, there were $47 in net savings. The probability for costeffectiveness using $50 000 per QALY as the threshold for cost-effectiveness was 88.8% to 99.9%. Net monetary benefits for the intervention group were higher than for the control group using the EQ-VAS and SF-6D but not when the EQ-5D was used.
There is no official level of willingness to pay for a gained QALY in the United States, but $50 000 and $100 000 USD are often used. In Great Britain also there is no official level, but the National Institute for Health and Clinical Excellence applies $32 000 to $50 000 as acceptable values, and in Sweden a threshold of $37 500 has been used to guide decisions about subsidized medicine. Thus, the cost-effectiveness of the intervention was good in relation to what Western countries are willing to pay for a QALY, and the probability for costeffectiveness was very high in this study. Most important for the low cost-effectiveness ratio is the increase in patients' QOL. Higher QOL may also have had an impact on reducing the number of family physician visits, which enhanced good cost-effectiveness.
The main reasons for cost-effectiveness were the sustainable increases in exercise level and QOL compared with the control group. An important aspect in the performance of the intervention method was probably the long-time contact with the participants. Another important aspect was that the group activities generated rather low costs per participant.
STRENGTHS AND WEAKNESSES
The Björknäs study was performed in an ordinary primary care setting, typical of Northern and Western European health care systems, with limited resources. The intervention continued for the whole 3-year period, albeit with tapering of intensity, and attrition was rather low. More than half of those eligible were randomized, in contrast to most major intervention studies, 35 which strengthens the internal and external validity. The study population and the number of dropouts did not differ, nor did the size of the group of individuals who declined to participate. 20 All data were analyzed conservatively on an ITT basis.
Clinically relevant effect sizes were noted for many, but not all, outcomes, and the use of 2 valid and reliable QOL instruments provided similar results. The study was initially powered for anthropometric measurements, not for QOL, and may thus be too small to detect significant improvements in less responsive scales.
A strength of the health economic analysis is that it is completely based on data from the trial, and only the 3-year follow-up time was considered in the analysis. Hence, no assumptions are needed, except for expenses for PA. The assumed costs represent a common yearly Value of a QALY, $ Probability EQ RS SF-6D EQ-5D Figure 3 . Probability of cost-effectiveness using the 5-dimensional EuroQol-5D (EQ-5D), EuroQol visual analog scale (EQ-VAS), and 6-dimensional Short-Form 6D (SF-6D) instruments presented in a cost-effectiveness acceptability curve with $0, $10 000, $30 000, $50 000, and $100 000 as value of a quality-adjusted life-year (QALY).
fee at exercise centers in Sweden. If the fee is doubled (from $140 to $280), the costs per gained QALY were still very low: $456 to $1317, instead of $47 in net savings. The main uncertainty is from the underlying trial. This uncertainty is managed according to recommendation from Drummond et al 29 when patient-level data are used. The NMB concept is an improvement in dealing with uncertainty compared with using sensitive analysis, especially when insignificant changes between groups are used in the calculation of cost-effectiveness ratios.
The costs for the participants' exercise time were not considered in this analysis. It is a topic concerning loss of enjoyment when exercising. For some individuals, PA may represent a loss of enjoyment, but those who frequently perform PA do not seem to lose enjoyment when spending time on exercise. 36 Neither were savings in production considered. In a situation with full employment, such savings may be important, but with significant unemployment, the savings will be restricted to costs of replacing a sick worker with a new one and will be of restricted magnitude.
The actual program and the Diabetes Prevention Program (DPP) 13 are 2 of few interventions lasting for 3 years. The DPP was an intense lifestyle program and showed a treatment effect compared with placebo of 0.07 QALY in 3 years, very similar to the findings of the Björknäs study. That program was very costly ($2780 for program holder year 2000), with mostly individual meetings. Costs were more than 10 times higher than for the actual project, which mainly used group meetings, but despite the high costs, the DPP was cost-effective.
Most important for cost-effectiveness is the effect in QALY, but there is no gold standard for a method to estimate QALY. We have used tariffs based on all 3 standard techniques 29 (time trade-off, standard gamble, and rating scale), and the valuation of QOL is made by both patients and a general population. We think the result is more convincing when acceptable cost-effective ratios are achieved with different methods.
Probably the cost-effectiveness is even better. Gains in QOL may remain after the 3-year period. The actual analysis had only a treatment perspective, but there were also preventive effects against cardiovascular diseases and type 2 DM. 20 Several lifestyle interventions have shown good cost-effectiveness from only a preventive perspective for similar patient groups. 19 Furthermore, the results are likely to be an underestimate because the control group received more promotion of healthy lifestyle than is generally common in primary health care.
Thus, high-intensity and long-lasting interventions can produce sustainable improvements in QOL and can obviously be cost-effective. Such programs may be a wise use of resources in primary health care for patients with diseases to which inactivity strongly contributes.
